Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 33 - Medicinal preparations containing inorganic active ingredients
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
03/2005
03/23/2005EP1515753A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
03/23/2005EP1515749A1 Combined use of a modulator of cd3 and a glp-1 compound
03/23/2005EP1515732A1 Cerebral protection with a gas comprising xenon
03/23/2005EP1515731A1 Anti-spasmodic comprising xenon
03/23/2005EP1515712A2 Use of taurine for the treatment of alopecia
03/23/2005EP1227764B1 Microdermabrasion device
03/23/2005CN1599716A Aminoacetonitrile derivatives and their use for controlling parasites
03/23/2005CN1599702A Antimicrobial alkali-silicate glass ceramic and the use thereof
03/23/2005CN1599618A Stabilization of hypoxia inducible factor (HIF) alpha
03/23/2005CN1596909A Production method of disodium adenosine triphosphate magnesium chloride injection
03/23/2005CN1596762A Production method and equipment of calcium-contained beverage
03/23/2005CN1193781C Medicine for treating aphtha
03/23/2005CN1193780C Excernally applied plaster using paper as paper as carrier for treating beriberi
03/23/2005CN1193751C Therpauetic agent of osteoporisis comprising active ingredient of quercetin derivatives
03/23/2005CN1193744C Slow releasing micro-encapsulation compound antioxidant
03/22/2005US6869944 Method for treating a patient with neoplasia by treatment with a platinum coordination complex
03/22/2005US6869626 Heating and melting the gold leaf fragments by combustion of hydrogen and oxygen in highly pressurized water to obtain an aqueous ultrafine gold particle solution health drink
03/18/2005CA2441710A1 Oral rinse
03/17/2005WO2005023274A1 Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium
03/17/2005WO2005023240A2 Pharmaceutical combination preparation containing glycyrrhizine, zinc, and a compound comprising a thiol group or a group that is metabolized thereto
03/17/2005WO2005023239A1 Pharmaceutical composition comprising i.a. vitamin c, magnesium, green tea extract for retarding cardiovascular diseases
03/17/2005WO2005023213A1 Body care product containing porous silver particles
03/17/2005WO2005023206A2 Silver-and zinc-containing body care agent
03/17/2005WO2005023020A1 Composition and method for facilitating bone healing
03/17/2005WO2005004915A3 Compositions comprising meloxicam
03/17/2005WO2004103408A3 Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine
03/17/2005WO2004066954A3 A therapeutic composition for the treatment of hiv-1 and hiv-2
03/17/2005US20050059979 Use of vibration with orthopedic cements
03/17/2005US20050059738 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
03/17/2005US20050059116 Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents
03/17/2005US20050059093 Method for detecting modulators of Notch signalling
03/17/2005US20050059008 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
03/17/2005US20050058730 Dry powdered extract from medicinal herbs mixed with vitamins, minerals, sheep liver and/or carrot root; health foods, cakes, candy, bread, chocolate
03/17/2005US20050058725 Gelatinase inhibitors; anticancer agents
03/17/2005US20050058724 Fluid therapy with l-lactate and/or pyruvate anions
03/17/2005US20050058722 Mixture of arsenic trioxide and Aloe Vera, Withania Somnifera, Glycine Max, Rubia Cordifolia and/or Acacia Catechu or their extracts; myelodysplastic syndrome, aplastic anemias
03/17/2005US20050058721 Coagulant and zeolite type A ion exchanged with oxide(s) of calcium, sodium, potassium, silver, magnesium disposed in binder; moisture content of zeolite is adjusted by drying and rehydration; clotting blood in wounds
03/17/2005US20050058720 Administering thiomolybdate to bind copper and form tripartite complex with protein; ocular, corneal or retinal/choroidal neovascularization, glaucoma, diabetes, delayed wound healing, burns, Osler-Weber Syndrome, psoriasis, parasitic diseases or atherosclerosis; antitumor and anticarcinogenic agents
03/17/2005US20050058718 Liquid additive and health pill reduce toxicity in tobacco smoke; health, treating nicotine addiction to quit smoking; decreasing dopamine and glutamic acid with copper and manganese compounds; vitamin B6 turns glutamic acid into g-aminobutyric acid; antioxidant use of vitamin C, E, & A
03/17/2005US20050058717 Fluid flow of calcium phosphate cementin conjunction with vibration; drug delivery; controlled penetration; cancer treatment
03/17/2005US20050058713 Photosensitizer functionalised nanoparticles
03/17/2005US20050058672 Baby Care Skin Protectant Compositions for Diaper Rash
03/17/2005US20050058605 gas or air filled microballoons in aqueous suspension; imaging contrast agent; ultrasonic echography
03/17/2005CA2532941A1 Composition and method for facilitating bone healing
03/17/2005CA2532161A1 Pharmaceutical composition comprising i.a. vitamin c, magnesium, green tea extract for retarding cardiovascular diseases
03/16/2005EP1513560A2 Method of magnetically manipulating a cell with magnetisable particles
03/16/2005EP1513546A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone
03/16/2005EP1353693B1 Pharmaceutical combination containing a 4-quinazolineamine and paclitaxel, carboplatin or vinorelbine for the treatment of cancer
03/16/2005EP1115371B1 Oral care compositions
03/16/2005CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
03/16/2005CN1596111A Methods and compositions for ameliorating the undesirable effects of chemotherapy
03/16/2005CN1593459A Process for preparing arsenic magnetized nanometer glutin minipill
03/16/2005CN1593458A Instant nutrition intensifying agent
03/16/2005CN1593457A Anti infection agent and its application
03/16/2005CN1593456A Desensitization face pack for treating facial dermatitis
03/16/2005CN1593455A Compound baking soda injection and its preparation
03/16/2005CN1593454A Magnesium, potassium and calcium mixture and its usage
03/16/2005CN1593453A Sterilizing and bacteria inhibiting pharmaceutical composition and its formulation and preparation process
03/16/2005CN1593396A Liquor for increasing cow born ratio and its manufacturing method
03/16/2005CN1192802C Bioactivity compound bone material and preparation method thereof
03/16/2005CN1192789C Diabetes treating tea and preparing method thereof
03/16/2005CN1192787C Chinese medicine for treating ulcerative colitis and its preparing process
03/15/2005US6867176 Method for preparing zinc-oligopeptide easily absorbable by the human body
03/15/2005US6866869 Liquid antimicrobial compositions
03/15/2005US6866857 Oxalipatinum preparation packaging
03/15/2005CA2191769C Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents
03/12/2005CA2440784A1 Anti-bacterial, anti-viral, and anti-fungus composition, its preparation and use
03/10/2005WO2005020879A2 Compositions for treating pathologies that necessitate suppression of gastric acid secretion
03/10/2005WO2005020876A2 Pharmaceutical composition, method of manufacturing and therapeutic use thereof
03/10/2005WO2005020689A1 Anti-virus hydrophilic polymeric material
03/10/2005WO2005000355A8 Treatment of tumor by cotransferring chemotherapeutic agent with cytokine gene
03/10/2005WO2004098619A3 Treating cartilage / bone conditions with water-soluble strontium salts
03/10/2005WO2004091497A3 Methods and compositions for increasing the anaerobic working capacity in tissues
03/10/2005WO2004087105A8 Combination formulations of platinum agents and fluoropyrimidines
03/10/2005US20050054717 Coumarin derivative
03/10/2005US20050054682 Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
03/10/2005US20050054663 GSK-3 inhibitors
03/10/2005US20050054585 Using saccharide; bone disorders
03/10/2005US20050054580 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells
03/10/2005US20050053676 Powdered composition for use as laxative
03/10/2005US20050053675 Method of making, and the use of cytotoxic agents containing elemental selenium
03/10/2005US20050053674 Pharmaceutical composition and method for retardation of the progression of atherosclerosis
03/10/2005US20050053673 Nutraceutical formulation for healing human bone due to accidental fracture or surgical replacement or grafting, containing lysine, proline, ascorbic acid, copper, and vitamin B6
03/10/2005US20050053664 Reduced toxicity; enhance efficiency; side effect reduction; anticarcinogenic agent; administering to a cancer patient admixture having (((1,4)-linked beta -D-mannopyranose)17-((1,6)-linked- beta -D-galactopyranose)10)12) and a chemotherapeutic agent
03/10/2005US20050053619 Nose sprays for relief of congestion and pain using vegetable oils, menthol, benzoin, thymol and sodium bicarbonate in water
03/10/2005US20050053595 White cream bacteriostats, fungicide as vehicle for drug; receptivity
03/10/2005US20050053560 Use of a composition containing extracts of Vitis vinifera and lycopersicum for protecting the skin
03/10/2005US20050053556 Administering subcitrate, aluminate, oxide, salicylate, subgallate, stannate, phosphate, tribromphenate, subcarbonatate, subnitrate, and/or sodium tartrate salt of bismuth to treat halitosis associated with sulfite-reducing bacteria in gut
03/10/2005CA2537610A1 Pharmaceutical composition, method of manufacturing and therapeutic use thereof
03/10/2005CA2536906A1 Compositions for treating pathologies that necessitate suppression of gastric acid secretion
03/09/2005EP1512670A1 Electrolytic reduced water, anti-cancer drug, and producing method and apparatus thereof
03/09/2005EP1511521A1 Strontium-apatite-cement-preparations and the use thereof
03/09/2005EP1511501A1 A stable bicarbonate-based solution in a single container
03/09/2005EP1511457A1 A composition and method for inhibiting polar capsule discharge and protecting a subject from nematocyst sting
03/09/2005EP1196185B1 Novel use of hypo-osmotic saline solutions and medicine based on said solutions
03/09/2005EP1085884B1 Combination of compounds containing selenium and gemcitabine or mitomycin c
03/09/2005EP0673241B1 Use of a free radical quenching liposomal composition for the manufacture of a medicament for the treatment of inflammatory conditions
03/09/2005CN1592755A Anti-angiogenic peptides
03/09/2005CN1592627A Carbon dioxide compositions for external use and process for producing the same
03/09/2005CN1191845C Medicine for treating upper respiratory tract infection and its prepn
1 ... 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 ... 563